Filter posts

Biotech Leaders Warn: Shortsighted Policies Threaten Miracle Breakthroughs

Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of …

Why Are Patients Facing Higher Costs When They Go to the Pharmacy?

BIO is out with a new whiteboard video that explores why more and more patients …

Technology to Fight Malaria, Zika, and Other Mosquito-Related Diseases Is Being Blocked. Why?

Every year, mosquitos infect 500 million people with diseases and mosquito-borne illnesses claim nearly a …

Experts Weigh In on the Dangers of Importing Foreign Price Controls

Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead …

New Videos Show How “Fail First” Policies Can Fail Patients

Continued access to a stable treatment can make all the difference for patients with chronic …

Rare Disease Drug Development Increases but Challenges Remain

In a recent study published by Tufts University, researchers found that rare disease drug development …

Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right...

In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies …

A Sustainable Movement to Curb Cancer in Africa

In just two years, BIO Ventures for Global Health (BVGH) has made significant progress in …

New BIO White Paper: Incorporating Real-World Evidence Within the Label of an FDA-Approved Drug

In today’s increasingly connected world, health care researchers have access to previously unimaginable troves of …

Health security threats are real: What is Congress doing?

In a rare show of bipartisan agreement, Congress recently passed and yesterday President Trump signed into …